A $200 million transaction between owner Serán Bioscience and Bain Capital Life Sciences in 2024 helped support the buildout of the commercial-scale plant.
Categories:
Related Post
Amid data center boom, Rosendin parent expands executive structure
Rosendin Holdings, parent firm of the nationwide electrical subcontractor, has adopted a co-president model amid…
Gateway restarts Hudson Tunnel work as funding uncertainty lingers
The DOT is seeking to reclaim the money it has paid to the Gateway Development…
$16B Hudson Tunnel project begins boring
“We've taken the Trump admin to court five times … we’ve won five times,” said…